UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of sclerotic and winged seeds of Cyrtosia septentrionalis (Rchb. f.) Garay and Erythrorchis altissima (Blume) Blume (Orchidaceae)

TAIWANIA, 2023, Vol.68 (3), p.359-367

2023

Volltextzugriff (PDF)

Two new butanolides from the roots of Litsea acuminata

Phytochemistry letters, 2015-03, Vol.11, p.32-36

2015

Volltextzugriff (PDF)

Plant growth inhibiting α-pyrones from Alpinia speciosa

Phytochemistry (Oxford), 1994-05, Vol.36 (1), p.23-27

1994

Volltextzugriff (PDF)

Observation of zigzag and armchair edges of graphite using scanning tunneling microscopy and spectroscopy

Physical review. B, Condensed matter and materials physics, 2005-05, Vol.71 (19), p.193407.1-193407.4, Article 193406

2005

Volltextzugriff (PDF)

Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR -mutated Non-small Cell Lung Cancer

Anticancer research, 2022-05, Vol.42 (5), p.2583-2590

2022

Volltextzugriff (PDF)

Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer

Cancer medicine (Malden, MA), 2021-10, Vol.10 (20), p.6971-6984

2021

Volltextzugriff (PDF)

Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma

Japanese journal of ophthalmology, 2012-07, Vol.56 (4), p.383-389

2012

Volltextzugriff (PDF)

A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101

International journal of clinical oncology, 2020-05, Vol.25 (5), p.867-875

2020

Volltextzugriff (PDF)

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations

Medicina (Kaunas, Lithuania), 2021-09, Vol.57 (9), p.929

2021

Volltextzugriff (PDF)

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma

Chemotherapy (Basel), 2022-08, Vol.67 (3), p.142-151

2022

Volltextzugriff (PDF)

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

Frontiers in oncology, 2023-01, Vol.12, p.1080729-1080729

2023

Volltextzugriff (PDF)

Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2020-11, Vol.18 (11), p.2929-2941

2020

Volltextzugriff (PDF)

Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer

Anticancer research, 2024-06, Vol.44 (6), p.2725-2730

2024

Volltextzugriff (PDF)

Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)

Anticancer research, 2023-10, Vol.43 (10), p.4583-4591

2023

Volltextzugriff (PDF)

A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632

Lung cancer (Amsterdam, Netherlands), 2021-11, Vol.161, p.49-54

2021

Volltextzugriff (PDF)

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

Thoracic cancer, 2022-10, Vol.13 (19), p.2776-2785

2022

Volltextzugriff (PDF)

A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients

Cancer chemotherapy and pharmacology, 2017-09, Vol.80 (3), p.615-622

2017

Volltextzugriff (PDF)

Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations

Cancer chemotherapy and pharmacology, 2018-07, Vol.82 (1), p.119-127

2018

Volltextzugriff (PDF)

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy

Oncology, 2021-08, Vol.99 (9), p.562-570

2021

Volltextzugriff (PDF)

Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)

In vivo (Athens), 2023-09, Vol.37 (5), p.2203-2209

2023

Volltextzugriff (PDF)

Clinical characteristics of hemodialysis patients with non-occlusive mesenteric ischemia

Nihon Tōseki Igakkai Zasshi, 2023, Vol.56 (6), p.205-213

2023

Volltextzugriff (PDF)

Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis

Thoracic cancer, 2020-10, Vol.11 (10), p.2867-2876

2020

Volltextzugriff (PDF)

Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study

Anticancer research, 2018-05, Vol.38 (5), p.3145-3150

2018

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(67)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(72)
Tagungsberichte
(1)

Sprache

Englisch
(73)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of sclerotic and winged seeds of Cyrtosia septentrionalis (Rchb. f.) Garay and Erythrorchis altissima (Blume) Blume (Orchidaceae)

Two new butanolides from the roots of Litsea acuminata

Plant growth inhibiting α-pyrones from Alpinia speciosa

Observation of zigzag and armchair edges of graphite using scanning tunneling microscopy and spectroscopy

Prognostic Implication of PD-L1 Expression on Osimertinib Treatment for EGFR -mutated Non-small Cell Lung Cancer

Pretreatment Glasgow prognostic score predicts survival among patients with high PD‐L1 expression administered first‐line pembrolizumab monotherapy for non‐small cell lung cancer

Clinical features and diagnostic significance of the intraocular fluid of 217 patients with intraocular lymphoma

A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101

Effectiveness and Safety of EGFR-TKI Rechallenge Treatment in Elderly Patients with Advanced Non-Small-Cell Lung Cancer Harboring Drug-Sensitive EGFR Mutations

Clinical Outcomes of Postoperative Adjuvant Chemotherapy for Surgically Resected High-Grade Pulmonary Neuroendocrine Carcinoma

Pretreatment glasgow prognostic score predicts survival among patients administered first-line atezolizumab plus carboplatin and etoposide for small cell lung cancer

Success and limitations of plasma treatment in pregnant women with congenital thrombotic thrombocytopenic purpura

Real Clinical Practice of Combined Atezolizumab Plus Chemotherapy in Patients With Small Cell Lung Cancer

Atezolizumab for EGFR-mutated Non-small Cell Lung Cancer Patients: An Observation Study in Ibaraki Group (ATTENTION-IBARAKI)

A prospective, phase II trial of monotherapy with low-dose afatinib for patients with EGFR, mutation-positive, non-small cell lung cancer: Thoracic oncology research group 1632

Treatment of Patients With Non-small-cell Lung Cancer With Uncommon EGFR Mutations in Clinical Practice

Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival

A retrospective study of amrubicin monotherapy for the treatment of relapsed small cell lung cancer in elderly patients

Efficacy and safety of cytotoxic drug chemotherapy after first-line EGFR–TKI treatment in elderly patients with non-small-cell lung cancer harboring sensitive EGFR mutations

Post-Progression Survival Influences Overall Survival among Patients with Advanced Non-Small Cell Lung Cancer Undergoing First-Line Pembrolizumab Monotherapy

Atezolizumab Monotherapy for Non-small Cell Lung Cancer Patients: An Observational Study in Ibaraki Group (ATTENTION-IBARAKI)

Clinical characteristics of hemodialysis patients with non-occlusive mesenteric ischemia

Real Clinical Practice in ALK-rearranged NSCLC Patients: A Retrospective Observational Study

Efficacy and safety of S‐1 monotherapy in previously treated elderly patients (aged ≥75 years) with non‐small cell lung cancer: A retrospective analysis

Acquired EGFR T790M Mutation After Relapse Following EGFR-TKI Therapy: A Population-based Multi-institutional Study

Suchergebnisse filtern